Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinpei Growth Hormone Injection in Short Stature Children With Small for Gestational Age (SGA)
NCT07841678Phase 3Not yet recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Small for gestational age (SGA) (2 arms), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd. Primary endpoint: Annualized Height Velocity at 52 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT07841678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841678.